ClinicalTrials.govpublic full text
XIENCE 28 USA Study
bleeding disorder, ischemic stroke, hemorrhagic stroke, hematological diseases, thrombocytopenia, coagulation disorder, anemia, renal insufficiency, coronary artery disease, high bleeding risk (hbr), dual antiplatelet therapy (dapt), drug eluting stent (des)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 875602
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.